John Kozlowski
Net Worth

Last updated:

What is John Kozlowski net worth?

The estimated net worth of Mr. John Kozlowski is at least $2,127,360 as of 14 Dec 2021. He has received compensation worth at least $2,127,360 in Lannett Company, Inc..

What is the salary of John Kozlowski?

Mr. John Kozlowski salary is $531,840 per year as Vice President of Fin., Chief Financial Officer & Principal Accounting Officer in Lannett Company, Inc..

How old is John Kozlowski?

Mr. John Kozlowski is 53 years old, born in 1972.

What stocks does John Kozlowski currently own?

As insider, Mr. John Kozlowski owns shares in one company:

Company Title Shares Price per share Total value
Lannett Company, Inc. (LCI) Vice President of Fin., Chief Financial Officer & Principal Accounting Officer 157,494 $0 $0

What does Lannett Company, Inc. do?

Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nasal, patch, foam, buccal, sublingual, suspensions, soft gel, injectable, and oral dosages. It also provides its products for various medical indications, such as analgesic, anti-psychosis, cardiovascular, central nervous system, endocrinology, gastrointestinal, infectious disease, migraine, respiratory/allergy/cough/cold, urinary, and others medical indications. The company's primary products include Levothyroxine Sodium tablets, Fluphenazine tablets, Posaconazole DR tablets, Verapamil SR tablets, Methylphenidate CD capsules, Omeprazole capsules, Pantoprazole Sodium DR tablets, Sumatriptan Nasal spray, Metolazone tablets, Amphetamine IR Tablets, Methylphenidate Hydrochloride ER stimulants, as well as cocaine hydrochloride solution. It sells its pharmaceutical products to generic pharmaceutical distributors, drug wholesalers, chain drug retailers, private label distributors, mail-order pharmacies, other pharmaceutical companies, managed care organizations, hospital buying groups, governmental entities, and health maintenance organizations. The company has supply and development agreements with Summit Bioscience LLC, HEC Group of companies, Dexcel Pharma, Elite Pharmaceuticals, RivoPharm, and various other companies. Lannett Company, Inc. was incorporated in 1942 and is headquartered in Trevose, Pennsylvania.

John Kozlowski insider trading

Lannett Company, Inc.

Transaction Date Security Shares Price per share Total value Source
Purchase
Common Stock 4,900 $1.81 $8,869
Purchase
Common Stock 4,000 $1.68 $6,720
Purchase
Common Stock 7,000 $2.06 $14,420

Lannett Company key executives

Lannett Company, Inc. executives and other stock owners filed with the SEC: